Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by 조용준, Executive. Director active across 3 companies, notably 동구바이오제약. Cumulatively, 123 filings have been recorded. Activity tracked since 1 April 2026. The latest transaction was filed on 22 April 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Jo Yong-jun is an executive at Donggu Bio Pharmaceutical, where he is involved in the operations and management of the company. While his specific role is not detailed, he contributes to the strategic direction and efficiency of processes within the organization, thereby supporting Donggu Bio Pharmaceutical's overall goals.